Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79211-x ◽

2008 ◽

Vol 2008 ◽

pp. 199-200

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemoradiation ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

Reports of Practical Oncology & Radiotherapy ◽

10.1016/j.rpor.2013.03.303 ◽

2013 ◽

Vol 18 ◽

pp. S262

Author(s):

J. Casal ◽

U. Anido ◽

N. Garcia ◽

S. Varela ◽

X. Fírvida ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemoradiation ◽

Stage Iii ◽

Small Cell Lung ◽

Download Full-text

A phase II study of concurrent pemetrexed and radiation for poor-risk stage III non-small cell lung cancer (NSCLC): Hoosier Oncology Group LUN08-129.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e17529 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e17529-e17529

Author(s):

J. L. Feliciano ◽

N. H. Hanna ◽

A. Fakiris ◽

M. Yu ◽

W. M. Dugan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Download Full-text

A randomized phase II study of concurrent chemoradiation with weekly paclitaxel or carboplatin in stage III unresectable non small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(00)80263-1 ◽

2000 ◽

Vol 48 (3) ◽

pp. 234 ◽

Author(s):

D Antonadou ◽

M Veslemes ◽

P Komi ◽

N Bolanos ◽

M Synodinou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemoradiation ◽

Stage Iii ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study

Lung Cancer ◽

10.1016/j.lungcan.2008.02.024 ◽

2008 ◽

Vol 62 (1) ◽

pp. 62-71 ◽

Author(s):

Remei Blanco ◽

Josep Solé ◽

Jesús Montesinos ◽

Carlos Mesía ◽

Manuel Algara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemoradiation ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

Lung Cancer ◽

10.1016/s0169-5002(00)80374-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 113

Author(s):

M Dediu ◽

T Horvat ◽

A Tarlea ◽

A Nicodin ◽

M Movanu ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

P1.12-02 Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.837 ◽

2018 ◽

Vol 13 (10) ◽

pp. S573

Author(s):

S. Igawa ◽

T. Fukui ◽

M. Shirasawa ◽

T. Ozawa ◽

H. Sone ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Extensive Disease ◽

Poor Risk ◽

Download Full-text

2145 Phase II study of induction chemotherapy followed by radiotherapy combined with daily Cisplatin in stage III inoperable non-small cell lung cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(97)80912-1 ◽

1997 ◽

Vol 39 (2) ◽

pp. 313

Author(s):

T. Scolaro ◽

A. Ardizzoni ◽

S. Giudici ◽

F. Grossi ◽

M. Cosso ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

A phase II study of induction docetaxel/cisplatin with rhG-CSF and concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7273 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7273-7273

Author(s):

Y. Chen ◽

P. Kishan ◽

T. Smudzin ◽

D. W. Johnstone ◽

T. J. Watson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7586 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7586-7586

Author(s):

K. W. Maas ◽

S. Y. Sharouni ◽

E. C. Phernambucq ◽

J. A. Stigt ◽

H. J. Groen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung ◽

Weekly Docetaxel ◽

Concurrent Radiotherapy

Download Full-text

Phase II study of weekly carboplatin/gemcitabine + concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e18515 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e18515-e18515

Author(s):

Manuel Domine ◽

Cristina Carames Sanchez ◽

Francisco Lobo ◽

Tatiana Carolina Hernandez Guerrero ◽

Ana Leon ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text